We are live on ! Find out more
BNTX icon

BioNTech
BNTX

254 hedge funds and large institutions have $4.97B invested in BioNTech in 2025 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 70 increasing their positions, 88 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

6% less first-time investments, than exits

New positions opened: 34 | Existing positions closed: 36

1.37% less ownership

Funds ownership: 22.37% → 21% (-1.4%)

2% less funds holding

Funds holding: 258 → 254 (-4)

13% less capital invested

Capital invested by funds: $5.72B → $4.97B (-$750M)

20% less repeat investments, than reductions

Existing positions increased: 70 | Existing positions reduced: 88

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

29% less call options, than puts

Call options by funds: $113M | Put options by funds: $159M

Holders
254
Holders Change
-4
Holders Change %
-1.55%
% of All Funds
3.33%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.04%
New
34
Increased
70
Reduced
88
Closed
36
Calls
$113M
Puts
$159M
Net Calls
-$45.9M
Net Calls Change
-$15.3M

Top Buyers

Rank Fund Capital Flow
1
Dodge & Cox
Dodge & Cox
California
+$296M
2
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
+$132M
3
Bank of America
Bank of America
North Carolina
+$47.5M
4
Citadel Advisors
Citadel Advisors
Florida
+$41.4M
5
UBS Group
UBS Group
Switzerland
+$37.3M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$289M
2
P
Pfizer
New York
-$214M
3
Invesco
Invesco
Georgia
-$64.9M
4
BlackRock
BlackRock
New York
-$58.7M
5
Bank of New York Mellon
Bank of New York Mellon
New York
-$57.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
AAS
276
Ameritas Advisory Services
Nebraska
– -$10.3K -97 Closed
GWS
277
Greykasell Wealth Strategies
California
– -$9.69K -91 Closed
S
278
Sachetta
Massachusetts
– -$6.25K -59 Closed
WT
279
Whittier Trust
California
– -$5.54K -52 Closed
GC
280
Garde Capital
Washington
– -$5.32K -50 Closed
NC
281
NewSquare Capital
Pennsylvania
– -$3.94K -37 Closed
PWA
282
Physician Wealth Advisors
Utah
– -$2.56K -24 Closed
VWWMG
283
Vermillion & White Wealth Management Group
Pennsylvania
– -$2.13K -20 Closed
AAP
284
Arax Advisory Partners
Colorado
– -$1.06K -10 Closed
SO
285
Sierra Ocean
California
– -$852 -8 Closed
WA
286
Whipplewood Advisors
Colorado
– -$745 -7 Closed
CI
287
CX Institutional
Indiana
– -$1K -5 Closed
AWM
288
Atticus Wealth Management
Florida
– -$213 -2 Closed
TIM
289
Total Investment Management
Arizona
– -$106 -1 Closed
8 9 10 11
12

BNTX Hedge Fund Activity: Q3 2025 in Review

254 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in BioNTech (BNTX) for Q3 2025, worth a combined $4.97B — down 13% from $5.72B a quarter earlier.

Sellers outnumbered buyers: 36 funds closed out of BNTX and 34 opened new positions — a net loss of 2 holders — while 88 trimmed existing stakes and 70 added.

The largest buyer was Dodge & Cox, adding an estimated $296M. The largest seller was Fidelity Investments, cutting an estimated $289M.

  • 254 institutional investors held BioNTech (BNTX) as of Q3 2025, down from 258 in Q2 2025.
  • Funds reported $4.97B of BioNTech stock for Q3 2025, down 13% quarter-over-quarter.
  • 34 funds opened new BioNTech positions in Q3 2025 and 36 closed out, a net change of -2 holders.
  • The largest BioNTech buyer in Q3 2025 was Dodge & Cox, an estimated $296M added.
  • The largest BioNTech seller in Q3 2025 was Fidelity Investments, an estimated $289M sold.

Based on aggregated 13F filings for Q3 2025.